ATAI Life Sciences N.V (NASDAQ:ATAI) currently has a daily average trading volume of 2.19M but it saw 1069793 shares traded in last market. With a market cap of 451.69M USD, the company’s current market price of $2.25 came rising about 2.27 while comparing to the previous closing price of $2.2. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.64 and as low as $1.03.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which reiterated the stock as “Buy” in its note to investors issued on November 18, 2024, recommending a price target of between $15 and $10 for it. Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on April 03, 2024 while assigning a price target of $6. Loop Capital issued its recommendations for the stock as it initiated the price target for the stock is $18.
Over the week, ATAI’s stock price is moving -3.43% down while it is 1.81% when we observe its performance for the past one month. Year-to-date it is 60.71% up and over the past year, the stock is showing an upside performance of 69.17%.
Currently, ATAI Life Sciences N.V’s total number of outstanding shares is 199.78M. Company’s return on investment (ROI) stands at -77.36% and return on equity (ROE) at -62.43%. Stock’s beta reads 1.47. Stock has a price to book (P/B) ratio of 2.96 while price to sale or P/S ratio amounts to 1368.76. Its return on asset (ROA) is -50.86% on average.
